Sorafenib and Low Dose Cytarabine in Treating Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

This study is ongoing, but not recruiting participants.

Study NCT00516828 Information provided by NCIC Clinical Trials Group

First Received: August 14, 2007 Last Updated: September 28, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	October 2011
Primary Completion Date:	March 2010 (Final data collection date for primary outcome measure)